Global Endovenous Ablation Devices Market, By Application (Hospital, Research Institute, Clinic, Other), Technology (Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices, Non-Thermal Non-Tumescent (NTNT) Devices) – Industry Trends and Forecast to 2029.
Endovenous Ablation Devices Market Analysis and Size
Varicose vein surgery is one of the most common surgical procedures. Endovenous techniques have largely replaced the standard treatment of "high ligation and stripping" in many countries. There are numerous techniques available. Each has a distinct action style and may necessitate the use of different skills.
Data Bridge Market Research analyses that the endovenous ablation devices market which is expected to reach a CAGR of 6% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Endovenous Ablation Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Application (Hospital, Research Institute, Clinic, Other), Technology (Endovenous Laser Ablation Therapy (EVLT) Devices, Radiofrequency Ablation (RFA) Devices, Non-Thermal Non-Tumescent (NTNT) Devices)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
AngioDynamics (U.S.), AtriCure Inc. (U.S.), Eufoton srl (Italy), Johnson & Johnson Private Limited (U.S.), Medtronic (Ireland), Merit Medical Systems (U.S.), RF Medical Co. Ltd. (South Korea), Sciton (U.S.), Teleflex Incorporated (U.S.), Venclose Inc. (U.S.), Syneron Medical Ltd. (U.S.), biolitec AG (Germany), Lumenis Be Ltd. (Israel), Quanta System (Italy), Koninklijke Philips N.V (Netherlands), HealthTronics, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Endovenous ablation is an image-guided procedure, which is minimally invasive. Endovenous ablation is a procedure for the treatment of varicose veins. Endovenous means that the procedure is done inside the vein. Endovenous therapy is a minimally invasive procedure, which may offer potential benefits such as faster recovery, reduced complications, fewer physical limitations, and increased health-related quality of life. Endovenous ablation devices are used to treat varicose veins caused by chronic venous insufficiency (CVI). These devices are designed specifically for minimally invasive procedures. Large, swollen veins on the legs and feet are common symptoms of varicose veins disease. This occurs when veins fail to function properly, causing blood to flow inefficiently. Varicose veins can rupture or develop into varicose ulcers on the skin in severe cases.
Global Endovenous Ablation Devices Market Dynamics
Drivers
- Increasing prevalence of minimally invasive procedures
The market is expanding due to rising demand for minimally invasive procedures used to treat varicose veins. Varicose veins are a common problem that is traditionally treated with surgery. Minimally invasive techniques have been developed in recent years as alternatives to surgery in an attempt to reduce morbidity and improve recovery time. The most promising new techniques are radiofrequency ablation and endovenous laser ablation.
Along with this, the growing geriatric population, rising obesity prevalence, ageing, smoking, and lack of physical activity are major factors driving the endovenous ablation devices market. In the forecast period, technological advancements and continuous research and development in improving devices will create additional opportunities for the endovenous ablation devices market.
- Launch of innovative products
Manufacturers in the endovenous ablation devices market are focusing on increasing R&D investments in order to design and develop new and innovative endovenous ablation devices. For instance Medtronic plc, has created the VenaSeal Closure System, the only non-thermal, non-tumescent, and non-sclerosant procedure that uses a proprietary medical adhesive delivered endovenously to close the vein.
Opportunities
- Increasing incidence of venous diseases
The incidence of venous diseases is growing due to the changing lifestyle and rising population. This is expected to drive the demand for endovenous ablation devices in the coming years.
Restraints/Challenges
- Limitations associated with endovenous ablation techniques
A scarcity of skilled vascular surgeons, complications and limitations associated with endovenous ablation techniques in developing and underdeveloped countries, unfavourable reimbursement policies, and high device costs will obstruct the market's growth rate.
This endovenous ablation devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the endovenous ablation devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent developments
- In 2019, Medtronic plc announced the signing of a definitive agreement to acquire EPIX Therapeutics, Inc. (EPIX), a privately held medical device company that designs and manufactures a novel, catheter-based, temperature-controlled cardiac ablation system for the treatment of patients with cardiac arrhythmias (irregular heartbeats), such as atrial fibrillation (AF).
- In 2019, Venclose Inc., a privately held Silicon Valley medical device company focused on innovative venous reflux disease treatment procedures, and Viant, a Massachusetts-based ISO-certified medical device contract manufacturer, today announced a partnership for the manufacture of Venclose's next-generation VENCLOSE TM RF Ablation Catheter.
Global Endovenous Ablation Devices Market Scope
The endovenous ablation devices market is segmented on the basis of application and technology. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Application
- Hospital
- Research Institute
- Clinic
- Other
Technology
- Endovenous Laser Ablation Therapy (EVLT) Devices
- Radiofrequency Ablation (RFA) Devices
- Non-Thermal Non-Tumescent (NTNT) Devices
Endovenous Ablation Devices Market Regional Analysis/Insights
The endovenous ablation devices market is analysed and market size insights and trends are provided by country, application and technology as referenced above.
The countries covered in the endovenous ablation devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the endovenous ablation devices market due to the increased demand for minimally invasive treatment procedures, increasing prevalence of varicose veins, strong presence of key vendors and increased healthcare expenditure.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the development of various treatment methods for chronic vascular insufficiency drive the market in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The endovenous ablation devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for endovenous ablation devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the endovenous ablation devices market. The data is available for historic period 2010-2020.
Competitive Landscape and Endovenous Ablation Devices Market Share Analysis
The endovenous ablation devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to endovenous ablation devices market.
Some of the major players operating in the endovenous ablation devices market are:
- AngioDynamics (U.S.)
- AtriCure Inc. (U.S.)
- Eufoton srl (Italy)
- Johnson & Johnson Private Limited (U.S.)
- Medtronic (Ireland)
- Merit Medical Systems (U.S.)
- RF Medical Co. Ltd. (South Korea)
- Sciton (U.S.)
- Teleflex Incorporated (U.S.)
- Venclose Inc. (U.S.)
- Syneron Medical Ltd. (U.S.)
- biolitec AG (Germany)
- Lumenis Be Ltd. (Israel)
- Quanta System (Italy)
- Koninklijke Philips N.V (Netherlands)
- HealthTronics, Inc. (U.S.)
SKU-